Sort
82,697 grants matching “vaccine development”
Antigen Processing And Presentation In The Intestine
$1,795,398Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$1,795,330Judith S. Currier · University Of California Los Angeles · UM1 · FY2016 · AI
Epidemiology and Ecology of Vibrio cholerae in Bangladesh
$1,794,507Richard Bradley Sack · Johns Hopkins University · R01 · FY2013 · AI
Task C02: Production and Development of Filarial Research Reagents
$1,794,504Andrew Riddel · University Of Georgia · N01 · FY2019 · AI
Mechanisms and Intracellular Components in Exocytosis, Membrane Assembly and Repair, and Parasite Replication
$1,794,330Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Respiratory Immunity Against Agents of Bioterrorism
$1,794,068Steven B. Mizel · Wake Forest University Health Sciences · P01 · FY2007 · AI
HIV Vaccine Design and Dev. Teams for Preventation and Treatment
$1,793,396Fran Volz · United Biomedical, Inc. · N01 · FY2009 · AI
SPORE in Prostate Cancer
$1,793,395William George Nelson · Johns Hopkins University · P50 · FY2015 · CA
Exploring HIV-Host Interactions in the Female Reproductive Tract
$1,793,394Warner C Greene · J. David Gladstone Institutes · P01 · FY2009 · AI
Malaria Vaccine: CSP-rEPA
$1,793,249Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS
$1,792,234John Eldridge · Profectus Biosciences, Inc. · N01 · FY2009 · AI
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,792,105Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Development of a Vaccine for HIVAIDS: Humoral Immunity
$1,792,105Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Prevention of AIDS
$1,791,918Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
$1,791,800Wayne M Sullender · University Of Alabama At Birmingham · U01 · FY2009 · IP
The AIDS Linked to the Intravenous Experience (ALIVE) Study
$1,791,772Gregory D Kirk · Johns Hopkins University · U01 · FY2017 · DA
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,791,614Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2024 · AG
Novel approaches for vaccine design
$1,791,237Michel C Nussenzweig · Rockefeller University · P01 · FY2010 · AI
Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs
$1,790,906Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · P01 · FY2019 · AI
Toward a Universal Influenza Virus Vaccine
$1,790,702Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · AI
Structural dynamics of single Ebolavirus GP molecules.
$1,790,553James B Munro · Tufts University Boston · DP2 · FY2015 · AI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,790,298Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,790,153Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,789,624Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Development of a Vaccine for HIVAIDS: Humoral Immunity
$1,789,624Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA